A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

As of Friday, January 23, Coherus Oncology, Inc.’s CHRS share price has surged by 21.70%, which has investors questioning if ...

In this phase 2 study, researchers aimed to determine whether adding elraglusib to gemcitabine and nab-paclitaxel improved survival in patients with treatment-naïve metastatic PDAC.

With a median follow-up of 4.2 years, patients receiving blinatumomab achieved a 4-year disease-free survival (DFS) of 83.3% ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, including Crohn’s diseas | Immunology ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

A hidden immune cascade linking the gut and bone marrow may explain how IBD turns inflammation into colon cancer.

Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.

Greenwich's $3.81 million cash position covers less than two months of operations, making near-term financing highly likely ...

The ‘TL1A’ messenger protein of the immune system triggers gut-to-bone marrow reaction, increasing the colorectal cancer risk ...